▶ 調査レポート

世界の神経保護剤市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Neuroprotective Agents Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の神経保護剤市場 2021:企業別、地域別、種類・用途別 / Global Neuroprotective Agents Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-107A14831資料のイメージです。• レポートコード:GIR-107A14831
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、神経保護剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。神経保護剤の種類別市場規模(脳血管障害、神経変性疾患、眼科疾患、外傷性中枢神経系損傷)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・神経保護剤の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Genervon Biopharmaceuticals、NeuroVive Pharmaceutical、Ceregene、Neuren Pharmaceuticals、Allon Therapeutics
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:脳血管障害、神経変性疾患、眼科疾患、外傷性中枢神経系損傷
・用途別分析2016年-2026年:病院、クリニック、その他
・神経保護剤の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・神経保護剤のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・神経保護剤のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・神経保護剤の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・神経保護剤の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Neuroprotective Agents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Neuroprotective Agents size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Neuroprotective Agents market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Neuroprotective Agents market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Cerebrovascular Diseases
Neurodegenerative Disorders
Ophthalmic Diseases
Traumatic CNS Injuries

Market segment by Application can be divided into
Hospitals
Clinics
Others

The key market players for global Neuroprotective Agents market are listed below:
Genervon Biopharmaceuticals
NeuroVive Pharmaceutical
Ceregene
Neuren Pharmaceuticals
Allon Therapeutics

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Neuroprotective Agents product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neuroprotective Agents, with price, sales, revenue and global market share of Neuroprotective Agents in 2018 and 2019.
Chapter 3, the Neuroprotective Agents competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuroprotective Agents breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Neuroprotective Agents market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Neuroprotective Agents sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Neuroprotective Agents Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neuroprotective Agents Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Cerebrovascular Diseases
1.2.3 Neurodegenerative Disorders
1.2.4 Ophthalmic Diseases
1.2.5 Traumatic CNS Injuries
1.3 Market Analysis by Application
1.3.1 Overview: Global Neuroprotective Agents Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Neuroprotective Agents Market Size & Forecast
1.4.1 Global Neuroprotective Agents Sales in Value (2016-2026))
1.4.2 Global Neuroprotective Agents Sales in Volume (2016-2026)
1.4.3 Global Neuroprotective Agents Price by Type (2016-2026) & (USD/MT)
1.5 Global Neuroprotective Agents Production Capacity Analysis
1.5.1 Global Neuroprotective Agents Total Production Capacity (2016-2026)
1.5.2 Global Neuroprotective Agents Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neuroprotective Agents Market Drivers
1.6.2 Neuroprotective Agents Market Restraints
1.6.3 Neuroprotective Agents Trends Analysis
2 Manufacturers Profiles
2.1 Genervon Biopharmaceuticals
2.1.1 Genervon Biopharmaceuticals Details
2.1.2 Genervon Biopharmaceuticals Major Business
2.1.3 Genervon Biopharmaceuticals Neuroprotective Agents Product and Services
2.1.4 Genervon Biopharmaceuticals Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 NeuroVive Pharmaceutical
2.2.1 NeuroVive Pharmaceutical Details
2.2.2 NeuroVive Pharmaceutical Major Business
2.2.3 NeuroVive Pharmaceutical Neuroprotective Agents Product and Services
2.2.4 NeuroVive Pharmaceutical Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Ceregene
2.3.1 Ceregene Details
2.3.2 Ceregene Major Business
2.3.3 Ceregene Neuroprotective Agents Product and Services
2.3.4 Ceregene Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Neuren Pharmaceuticals
2.4.1 Neuren Pharmaceuticals Details
2.4.2 Neuren Pharmaceuticals Major Business
2.4.3 Neuren Pharmaceuticals Neuroprotective Agents Product and Services
2.4.4 Neuren Pharmaceuticals Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Allon Therapeutics
2.5.1 Allon Therapeutics Details
2.5.2 Allon Therapeutics Major Business
2.5.3 Allon Therapeutics Neuroprotective Agents Product and Services
2.5.4 Allon Therapeutics Neuroprotective Agents Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Neuroprotective Agents Sales by Manufacturer
3.1 Global Neuroprotective Agents Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Neuroprotective Agents Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Neuroprotective Agents
3.4 Market Concentration Rate
3.4.1 Top 3 Neuroprotective Agents Manufacturer Market Share
3.4.2 Top 6 Neuroprotective Agents Manufacturer Market Share
3.5 Global Neuroprotective Agents Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Neuroprotective Agents Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neuroprotective Agents Market Size by Region
4.1.1 Global Neuroprotective Agents Sales in Volume by Region (2016-2026)
4.1.2 Global Neuroprotective Agents Revenue by Region (2016-2026)
4.2 North America Neuroprotective Agents Revenue (2016-2026)
4.3 Europe Neuroprotective Agents Revenue (2016-2026)
4.4 Asia-Pacific Neuroprotective Agents Revenue (2016-2026)
4.5 South America Neuroprotective Agents Revenue (2016-2026)
4.6 Middle East and Africa Neuroprotective Agents Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Neuroprotective Agents Sales in Volume by Type (2016-2026)
5.2 Global Neuroprotective Agents Revenue by Type (2016-2026)
5.3 Global Neuroprotective Agents Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Neuroprotective Agents Sales in Volume by Application (2016-2026)
6.2 Global Neuroprotective Agents Revenue by Application (2016-2026)
6.3 Global Neuroprotective Agents Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Neuroprotective Agents Sales by Type (2016-2026)
7.2 North America Neuroprotective Agents Sales by Application (2016-2026)
7.3 North America Neuroprotective Agents Market Size by Country
7.3.1 North America Neuroprotective Agents Sales in Volume by Country (2016-2026)
7.3.2 North America Neuroprotective Agents Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Neuroprotective Agents Sales by Type (2016-2026)
8.2 Europe Neuroprotective Agents Sales by Application (2016-2026)
8.3 Europe Neuroprotective Agents Market Size by Country
8.3.1 Europe Neuroprotective Agents Sales in Volume by Country (2016-2026)
8.3.2 Europe Neuroprotective Agents Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Neuroprotective Agents Sales by Type (2016-2026)
9.2 Asia-Pacific Neuroprotective Agents Sales by Application (2016-2026)
9.3 Asia-Pacific Neuroprotective Agents Market Size by Region
9.3.1 Asia-Pacific Neuroprotective Agents Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Neuroprotective Agents Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Neuroprotective Agents Sales by Type (2016-2026)
10.2 South America Neuroprotective Agents Sales by Application (2016-2026)
10.3 South America Neuroprotective Agents Market Size by Country
10.3.1 South America Neuroprotective Agents Sales in Volume by Country (2016-2026)
10.3.2 South America Neuroprotective Agents Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neuroprotective Agents Sales by Type (2016-2026)
11.2 Middle East & Africa Neuroprotective Agents Sales by Application (2016-2026)
11.3 Middle East & Africa Neuroprotective Agents Market Size by Country
11.3.1 Middle East & Africa Neuroprotective Agents Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Neuroprotective Agents Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Neuroprotective Agents Typical Distributors
12.3 Neuroprotective Agents Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Neuroprotective Agents Revenue by Type, (USD Million), 2021-2026
Table 2. Global Neuroprotective Agents Revenue by Application, (USD Million), 2021-2026
Table 3. Genervon Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Genervon Biopharmaceuticals Major Business
Table 5. Genervon Biopharmaceuticals Neuroprotective Agents Product and Services
Table 6. Genervon Biopharmaceuticals Neuroprotective Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. NeuroVive Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. NeuroVive Pharmaceutical Major Business
Table 9. NeuroVive Pharmaceutical Neuroprotective Agents Product and Services
Table 10. NeuroVive Pharmaceutical Neuroprotective Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Ceregene Basic Information, Manufacturing Base and Competitors
Table 12. Ceregene Major Business
Table 13. Ceregene Neuroprotective Agents Product and Services
Table 14. Ceregene Neuroprotective Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Neuren Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Neuren Pharmaceuticals Major Business
Table 17. Neuren Pharmaceuticals Neuroprotective Agents Product and Services
Table 18. Neuren Pharmaceuticals Neuroprotective Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Allon Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Allon Therapeutics Major Business
Table 21. Allon Therapeutics Neuroprotective Agents Product and Services
Table 22. Allon Therapeutics Neuroprotective Agents Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Neuroprotective Agents Sales by Manufacturer (2019-2021e) & (K MT)
Table 24. Global Neuroprotective Agents Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Neuroprotective Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Neuroprotective Agents Production Capacity by Company, (K MT): 2020 VS 2021
Table 27. Head Office and Neuroprotective Agents Production Site of Key Manufacturer
Table 28. Neuroprotective Agents New Entrant and Capacity Expansion Plans
Table 29. Neuroprotective Agents Mergers & Acquisitions in the Past Five Years
Table 30. Global Neuroprotective Agents Sales by Region (2016-2021e) & (K MT)
Table 31. Global Neuroprotective Agents Sales by Region (2021-2026) & (K MT)
Table 32. Global Neuroprotective Agents Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global Neuroprotective Agents Revenue by Region (2021-2026) & (USD Million)
Table 34. Global Neuroprotective Agents Sales by Type (2016-2021e) & (K MT)
Table 35. Global Neuroprotective Agents Sales by Type (2021-2026) & (K MT)
Table 36. Global Neuroprotective Agents Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global Neuroprotective Agents Revenue by Type (2021-2026) & (USD Million)
Table 38. Global Neuroprotective Agents Price by Type (2016-2021e) & (USD/MT)
Table 39. Global Neuroprotective Agents Price by Type (2021-2026) & (USD/MT)
Table 40. Global Neuroprotective Agents Sales by Application (2016-2021e) & (K MT)
Table 41. Global Neuroprotective Agents Sales by Application (2021-2026) & (K MT)
Table 42. Global Neuroprotective Agents Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global Neuroprotective Agents Revenue by Application (2021-2026) & (USD Million)
Table 44. Global Neuroprotective Agents Price by Application (2016-2021e) & (USD/MT)
Table 45. Global Neuroprotective Agents Price by Application (2021-2026) & (USD/MT)
Table 46. North America Neuroprotective Agents Sales by Country (2016-2021e) & (K MT)
Table 47. North America Neuroprotective Agents Sales by Country (2021-2026) & (K MT)
Table 48. North America Neuroprotective Agents Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America Neuroprotective Agents Revenue by Country (2021-2026) & (USD Million)
Table 50. North America Neuroprotective Agents Sales by Type (2016-2021e) & (K MT)
Table 51. North America Neuroprotective Agents Sales by Type (2021-2026) & (K MT)
Table 52. North America Neuroprotective Agents Sales by Application (2016-2021e) & (K MT)
Table 53. North America Neuroprotective Agents Sales by Application (2021-2026) & (K MT)
Table 54. Europe Neuroprotective Agents Sales by Country (2016-2021e) & (K MT)
Table 55. Europe Neuroprotective Agents Sales by Country (2021-2026) & (K MT)
Table 56. Europe Neuroprotective Agents Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe Neuroprotective Agents Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe Neuroprotective Agents Sales by Type (2016-2021e) & (K MT)
Table 59. Europe Neuroprotective Agents Sales by Type (2021-2026) & (K MT)
Table 60. Europe Neuroprotective Agents Sales by Application (2016-2021e) & (K MT)
Table 61. Europe Neuroprotective Agents Sales by Application (2021-2026) & (K MT)
Table 62. Asia-Pacific Neuroprotective Agents Sales by Region (2016-2021e) & (K MT)
Table 63. Asia-Pacific Neuroprotective Agents Sales by Region (2021-2026) & (K MT)
Table 64. Asia-Pacific Neuroprotective Agents Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific Neuroprotective Agents Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Neuroprotective Agents Sales by Type (2016-2021e) & (K MT)
Table 67. Asia-Pacific Neuroprotective Agents Sales by Type (2021-2026) & (K MT)
Table 68. Asia-Pacific Neuroprotective Agents Sales by Application (2016-2021e) & (K MT)
Table 69. Asia-Pacific Neuroprotective Agents Sales by Application (2021-2026) & (K MT)
Table 70. South America Neuroprotective Agents Sales by Country (2016-2021e) & (K MT)
Table 71. South America Neuroprotective Agents Sales by Country (2021-2026) & (K MT)
Table 72. South America Neuroprotective Agents Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America Neuroprotective Agents Revenue by Country (2021-2026) & (USD Million)
Table 74. South America Neuroprotective Agents Sales by Type (2016-2021e) & (K MT)
Table 75. South America Neuroprotective Agents Sales by Type (2021-2026) & (K MT)
Table 76. South America Neuroprotective Agents Sales by Application (2016-2021e) & (K MT)
Table 77. South America Neuroprotective Agents Sales by Application (2021-2026) & (K MT)
Table 78. Middle East & Africa Neuroprotective Agents Sales by Country (2016-2021e) & (K MT)
Table 79. Middle East & Africa Neuroprotective Agents Sales by Country (2021-2026) & (K MT)
Table 80. Middle East & Africa Neuroprotective Agents Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa Neuroprotective Agents Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Neuroprotective Agents Sales by Type (2016-2021e) & (K MT)
Table 83. Middle East & Africa Neuroprotective Agents Sales by Type (2021-2026) & (K MT)
Table 84. Middle East & Africa Neuroprotective Agents Sales by Application (2016-2021e) & (K MT)
Table 85. Middle East & Africa Neuroprotective Agents Sales by Application (2021-2026) & (K MT)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. Neuroprotective Agents Typical Distributors
Table 89. Neuroprotective Agents Typical Customers
List of Figures
Figure 1. Neuroprotective Agents Picture
Figure 2. Global Neuroprotective Agents Sales Market Share by Type in 2020
Figure 3. Cerebrovascular Diseases
Figure 4. Neurodegenerative Disorders
Figure 5. Ophthalmic Diseases
Figure 6. Traumatic CNS Injuries
Figure 7. Global Neuroprotective Agents Sales Market Share by Application in 2020
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Neuroprotective Agents Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 12. Global Neuroprotective Agents Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Neuroprotective Agents Sales (2016-2026) & (K MT)
Figure 14. Global Neuroprotective Agents Price by Type (2016-2026) & (USD/MT)
Figure 15. Global Neuroprotective Agents Production Capacity (2016-2026) & (K MT)
Figure 16. Global Neuroprotective Agents Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Neuroprotective Agents Market Drivers
Figure 18. Neuroprotective Agents Market Restraints
Figure 19. Neuroprotective Agents Market Trends
Figure 20. Global Neuroprotective Agents Sales Market Share by Manufacturer in 2020
Figure 21. Global Neuroprotective Agents Revenue Market Share by Manufacturer in 2020
Figure 22. Neuroprotective Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Neuroprotective Agents Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Neuroprotective Agents Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Neuroprotective Agents Sales Market Share by Region (2016-2026)
Figure 26. Global Neuroprotective Agents Revenue Market Share by Region (2016-2026)
Figure 27. North America Neuroprotective Agents Revenue (2016-2026) & (USD Million)
Figure 28. Europe Neuroprotective Agents Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Neuroprotective Agents Revenue (2016-2026) & (USD Million)
Figure 30. South America Neuroprotective Agents Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Neuroprotective Agents Revenue (2016-2026) & (USD Million)
Figure 32. Global Neuroprotective Agents Sales Market Share by Type (2016-2026)
Figure 33. Global Neuroprotective Agents Revenue Market Share by Type (2016-2026)
Figure 34. Global Neuroprotective Agents Price by Type (2016-2026) & (USD/MT)
Figure 35. Global Neuroprotective Agents Sales Market Share by Application (2016-2026)
Figure 36. Global Neuroprotective Agents Revenue Market Share by Application (2016-2026)
Figure 37. Global Neuroprotective Agents Price by Application (2016-2026) & (USD/MT)
Figure 38. North America Neuroprotective Agents Sales Market Share by Type (2016-2026)
Figure 39. North America Neuroprotective Agents Sales Market Share by Application (2016-2026)
Figure 40. North America Neuroprotective Agents Sales Market Share by Country (2016-2026)
Figure 41. North America Neuroprotective Agents Revenue Market Share by Country (2016-2026)
Figure 42. United States Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Neuroprotective Agents Sales Market Share by Type (2016-2026)
Figure 46. Europe Neuroprotective Agents Sales Market Share by Application (2016-2026)
Figure 47. Europe Neuroprotective Agents Sales Market Share by Country (2016-2026)
Figure 48. Europe Neuroprotective Agents Revenue Market Share by Country (2016-2026)
Figure 49. Germany Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Neuroprotective Agents Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Neuroprotective Agents Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Neuroprotective Agents Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Neuroprotective Agents Revenue Market Share by Region (2016-2026)
Figure 58. China Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Neuroprotective Agents Sales Market Share by Type (2016-2026)
Figure 65. South America Neuroprotective Agents Sales Market Share by Application (2016-2026)
Figure 66. South America Neuroprotective Agents Sales Market Share by Country (2016-2026)
Figure 67. South America Neuroprotective Agents Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Neuroprotective Agents Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Neuroprotective Agents Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Neuroprotective Agents Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Neuroprotective Agents Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Neuroprotective Agents Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source